Active Recombinant Human NCR3LG1, Fc Chimera

• Cat.No.: NCR3LG1-706H
• Product Overview: Recombinant Human NCR3LG1 (Accession # NP_001189368) was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Species: Human
• Source: Mammalian Cells
• Tag: Fc
• Predicted N Terminal: Asp25
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by its ability to induce IFN-gamma secretion by NK-92 human natural killer lymphoma cells. Brandt, C.S. et al. (2009) J. Exp. Med. 206:1495.The ED50 for this effect is typically 0.6 - 3 µg/mL.
• Molecular Mass: Recombinant Human NCR3LG1, Fc Chimera has a calculated MW of 53.3 kDa (monomer). In SDS-PAGE migrates as 75-85 kDa, reducing conditions.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: NCR3LG1 natural killer cell cytotoxicity receptor 3 ligand 1 [ Homo sapiens (human) ]
• Official Symbol: NCR3LG1
• Synonyms: NCR3LG1; natural killer cell cytotoxicity receptor 3 ligand 1; B7H6; B7-H6; DKFZp686O24166; natural cytotoxicity triggering receptor 3 ligand 1; B7 homolog 6; putative Ig-like domain-containing protein DKFZp686O24166/DKFZp686I21167
• Gene ID: 374383
• mRNA Refseq: NM_001202439
• Protein Refseq: NP_001189368
• MIM: 613714
• UniProt ID: Q68D85
• Chromosome Location: 11p15.1